Prevalence, correlates and comorbidity of DSM-IV Cannabis Use and Cannabis Use Disorders in Australia
The DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.
Abstract
Objective: To report nationally representative findings on the prevalence, correlates, psychiatric comorbidity and treatment of DSM-IV Cannabis Use and Cannabis Use Disorders in Australia. Method: The 2007 National Survey of Mental Health and Wellbeing was a nationally representative household survey of 8841 Australians (16–85 years) that assessed symptoms of the most prevalent DSM-IV mental disorders. Results: Prevalence of lifetime and 12-month cannabis use was 18% and 6%; prevalence of lifetime and 12-month cannabis use disorder was 6% and 1%. The conditional prevalence (proportion of ever users who met criteria for a disorder) of lifetime and 12-month cannabis use disorder was 32.2% and 14.3%. Current cannabis use disorders were more common in males (OR 2.0) and younger users (OR 4.6). Strong associations were observed between current cannabis use disorders and alcohol use disorders (OR 3.6) and current affective disorders (OR 3.0). Only 36.2% of those with current cannabis use disorders sought any treatment. Conclusions: The prevalence of cannabis use disorders in the Australian population is comparable with that in the USA. Current cannabis use disorders are highly concentrated in young Australians who have high levels of comorbidity. The low rates of treatment seeking warrant attention in treatment and prevention strategies.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“over 40% of individuals with CUD have a comorbid anxiety disorder (Teesson et al., 2012).”
From Integrated cognitive behavioral therapy for comorbid cannabis use and anxiety disorders: A pilot randomized controlled trial (2019) · cites this paper as Teesson et al., 2012
Citations
Cites
Kessler, R. C., Berglund, P., Demler, O., Jin, R., Merikangas, K. R., & Walters, E. E. (2005) · Archives of General Psychiatry · doi:10.1001/archpsyc.62.6.593 · Cited by 20,391 · cited 1×
“The rates of use reported herein are similar to those reported in European countries, particularly France (19.0), Germany (17.5) and the Netherlands (19.8) (Degenhardt et al., 2008, Kessler and Ustun, 2004, Kessler et al., 2005, Wells et al., 2006).”
InfluentialKessler, R. C., & Üstün, T. B. (2004) · International Journal of Methods in Psychiatric Research · doi:10.1002/mpr.168 · Cited by 4,771 · cited 4×
“The rates of use reported herein are similar to those reported in European countries, particularly France (19.0), Germany (17.5) and the Netherlands (19.8) (Degenhardt et al., 2008, Kessler and Ustun, 2004, Kessler et al., 2005, Wells et al., 2006).”
InfluentialHasin, D. S., Stinson, F. S., Ogburn, E., & Grant, B. F. (2007) · Archives of General Psychiatry · doi:10.1001/archpsyc.64.7.830 · Cited by 2,908 · cited 2×
“It is crucial that epidemiological information be as upto-date and accurate as possible to reflect dynamic changes in patterns of drug use (Hasin et al., 2007).”
Compton, W. M., Thomas, Y. F., Stinson, F. S., & Grant, B. F. (2007) · Archives of General Psychiatry · doi:10.1001/archpsyc.64.5.566 · Cited by 1,152 · cited 5×
“…NSW 2052, Australia Email: m.teesson@unsw.edu.au Australian & New Zealand Journal of Psychiatry, 46(12) the prevalence of cannabis use disorders in the past year has ranged from 1.4% in New Zealand to 2.2% in the Australian population(Compton et al., 2007; Swift et al., 2001; Wells et al., 2006).”
InfluentialAdverse health effects of non-medical cannabis use
Hall, W., & Degenhardt, L. (2009) · The Lancet · doi:10.1016/s0140-6736(09)61037-0 · Cited by 1,134
Self-citation2007 National Survey of Mental Health and Wellbeing: Methods and Key Findings
Slade, T., Johnston, A., Oakley Browne, M. A., Andrews, G., & Whiteford, H. (2009) · Australian & New Zealand Journal of Psychiatry · doi:10.1080/00048670902970882 · Cited by 832 · cited 4×
“The youngest (16–24 years) and oldest (65–85 years) age groups had a higher probability of being selected to ensure sufficient samples sizes (Slade et al., 2009).”
InfluentialSelf-citationPrevalence of Marijuana Use Disorders in the United States: 1991-1992 and 2001-2002
Compton, W. M., Grant, B. F., Colliver, J. D., Glantz, M. D., & Stinson, F. S. (2004) · JAMA · doi:10.1001/jama.291.17.2114 · Cited by 537
Cannabis use and later life outcomes
Fergusson, D. M., & Boden, J. M. (2008) · Addiction · doi:10.1111/j.1360-0443.2008.02221.x · Cited by 526 · cited 2×
“This could be because people with cannabis use disorders find it difficult to find employment or, alternatively, because those who become unemployed or who leave the labour force may be more likely to use cannabis, and, hence, are at increased risk of a cannabis use disorder (Fergusson and Boden, 2008).”
Collins, D. J., & Lapsley, H. M. (2008) · PsycEXTRA Dataset · doi:10.1037/e674312010-001 · Cited by 425
Substance use, abuse and dependence in adolescence: prevalence, symptom profiles and correlates
Young, S. E., Corley, R. P., Stallings, M. C., Rhee, S. H., Crowley, T. J., & Hewitt, J. K. (2002) · Drug and Alcohol Dependence · doi:10.1016/s0376-8716(02)00225-9 · Cited by 341 · cited 1×
“It may also be a ‘diagnostic bias’, with younger age groups more frequently endorsing cannabis use disorder criteria, although there is little support to date for this hypothesis (Young et al., 2002).”
BackgroundCannabis use and educational achievement: Findings from three Australasian cohort studies
Horwood, L. J., Fergusson, D. M., Hayatbakhsh, M. R., Najman, J. M., Coffey, C., Patton, G. C., Silins, E., & Hutchinson, D. M. (2010) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2010.03.008 · Cited by 302 · cited 2×
“While cross-sectional surveys, such as the current one, provide little data on the causal relationship between cannabis use and outcomes such as employment, evidence from longitudinal studies suggests that increasing cannabis use is associated with failure to obtain school and university qualifications (Horwood et al.…”
Chen, C.-Y., O’Brien, M. S., & Anthony, J. C. (2005) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2004.11.014 · Cited by 260 · cited 3×
“smoking fractions of a ‘joint’ as opposed to a complete ‘joint’) (Chen et al., 2005).”
InfluentialConrod, P. J., Castellanos-Ryan, N., & Strang, J. (2010) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2009.173 · Cited by 259 · cited 1×
“There are a number of preventive interventions that have shown to be effective in delaying onset of cannabis use (Conrod et al., 2010) and reducing frequency of use (Newton et al., 2010).”
Teesson, M., Hall, W., Slade, T., Mills, K., Grove, R., Mewton, L., Baillie, A., & Haber, P. (2010) · Addiction · doi:10.1111/j.1360-0443.2010.03096.x · Cited by 230 · cited 2×
“The lack of health service utilisation among those with cannabis use disorders contrasts with much better rates for treatment of depression in Australia (Slade et al., 2009; Teesson et al., 2010).”
BackgroundResultSelf-citationCannabis potency and contamination: a review of the literature
McLaren, J., Swift, W., Dillon, P., & Allsop, S. (2008) · Addiction · doi:10.1111/j.1360-0443.2008.02230.x · Cited by 212 · cited 2×
“The THC content of Australian cannabis products has not been systematically tested; however, a systematic review of international evidence found that increased potency has been observed in some countries, but there is enormous variation between samples, meaning that cannabis users may be exposed to greater variation i…”
Self-citationWells, J. E., Oakley Browne, M. A., Scott, K. M., McGee, M. A., Baxter, J., & Kokaua, J. (2006) · Australian & New Zealand Journal of Psychiatry · doi:10.1080/j.1440-1614.2006.01903.x · Cited by 194 · cited 4×
“…NSW 2052, Australia Email: m.teesson@unsw.edu.au Australian & New Zealand Journal of Psychiatry, 46(12) the prevalence of cannabis use disorders in the past year has ranged from 1.4% in New Zealand to 2.2% in the Australian population(Compton et al., 2007; Swift et al., 2001; Wells et al., 2006).”
InfluentialCannabis use disorder: Epidemiology and management
Copeland, J., & Swift, W. (2009) · International Review of Psychiatry · doi:10.1080/09540260902782745 · Cited by 190 · cited 3×
“It is also true that the most commonly available intervention, cognitive–behavioural therapy, reduces cannabis use and cannabis-related issues, but only 15% of people remain abstinent 6–12 months after treatment (Copeland and Swift, 2009).”
Self-citationSwift, W., Coffey, C., Carlin, J. B., Degenhardt, L., & Patton, G. C. (2008) · Addiction · doi:10.1111/j.1360-0443.2008.02246.x · Cited by 181
Self-citationTrajectories of adolescent alcohol and cannabis use into young adulthood
Patton, G. C., Coffey, C., Lynskey, M. T., Reid, S., Hemphill, S., Carlin, J. B., & Hall, W. (2007) · Addiction · doi:10.1111/j.1360-0443.2006.01728.x · Cited by 179
Self-citationCannabis Use and Dependence: Public Health and Public Policy
(2005) · Australian & New Zealand Journal of Psychiatry · doi:10.1080/j.1440-1614.2005.01644_1.x · Cited by 178
Internet‐based prevention for alcohol and cannabis use: final results of the Climate Schools course
Newton, N. C., Teesson, M., Vogl, L. E., & Andrews, G. (2010) · Addiction · doi:10.1111/j.1360-0443.2009.02853.x · Cited by 176 · cited 2×
“, 2010) and reducing frequency of use (Newton et al., 2010).”
Self-citationvon Sydow, K., Lieb, R., Pfister, H., Höfler, M., Sonntag, H., & Wittchen, H.-U. (2001) · Drug and Alcohol Dependence · doi:10.1016/s0376-8716(01)00137-5 · Cited by 162
Cannabis Use and Dependence: Public Health and Public Policy
Hall, W., & Pacula, R. L. (2002) · Cambridge University Press eBooks · doi:10.1017/cbo9780511470219 · Cited by 146
Self-citationSwift, W., Hall, W., & Teesson, M. (2001) · Addiction · doi:10.1046/j.1360-0443.2001.9657379.x · Cited by 126 · cited 8×
“…NSW 2052, Australia Email: m.teesson@unsw.edu.au Australian & New Zealand Journal of Psychiatry, 46(12) the prevalence of cannabis use disorders in the past year has ranged from 1.4% in New Zealand to 2.2% in the Australian population(Compton et al., 2007; Swift et al., 2001; Wells et al., 2006).”
InfluentialSelf-citationOutcomes of occasional cannabis use in adolescence: 10-year follow-up study in Victoria, Australia
Degenhardt, L., Coffey, C., Carlin, J. B., Swift, W., Moore, E., & Patton, G. C. (2010) · British Journal of Psychiatry · doi:10.1192/bjp.bp.108.056952 · Cited by 122 · cited 1×
“This is of particular concern as recent research suggests that early cannabis use may lead to later drug problems (Degenhardt et al., 2010).”
Self-citationComorbid Forms of Psychopathology: Key Patterns and Future Research Directions
Cerda, M., Sagdeo, A., & Galea, S. (2008) · Epidemiologic Reviews · doi:10.1093/epirev/mxn003 · Cited by 108 · cited 1×
“Hypotheses about the nature and casual relationships between comorbid disorders cannot be fully examined in cross-sectional epidemiological studies such as the 2007 NSMHWB, and it is likely that the causal relationships operate in both directions and vary with age (Cerda et al., 2008).”
Teesson, M., Baillie, A., Lynskey, M. T., Manor, B. R., & Degenhardt, L. J. (2005) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2005.06.007 · Cited by 101 · cited 1×
“…comparison with the US National Comorbidity Survey found that although rates of use of cannabis were similar in the two countries, rates of cannabis dependence and the probability of dependence among users were higher in Australia than in the USA (McBride et al., 2009; Teesson et al., 2006).”
Self-citationErrors in Assessing DSM-IV Substance Use Disorders
Grant, B. F., Compton, W. M., Crowley, T. J., Hasin, D. S., Helzer, J. E., Li, T., Rounsaville, B. J., Volkow, N. D., & WOODY, G. E. (2007) · Archives of General Psychiatry · doi:10.1001/archpsyc.64.3.379 · Cited by 76 · cited 1×
“Sequencing problems in earlier versions of the WMH-CIDI substance use section were also resolved (Degenhardt et al., 2007a, 2007b; Grant et al. 2007)to enable the diagnosis of cannabis dependence to be made in the absence of cannabis abuse.”
de Graaf, R., Radovanovic, M., van Laar, M., Fairman, B., Degenhardt, L., Aguilar-Gaxiola, S., Bruffaerts, R., de Girolamo, G., Fayyad, J., Gureje, O., et al. (2010) · American Journal of Epidemiology · doi:10.1093/aje/kwq096 · Cited by 75 · cited 1×
“Despite earlier suggestions that cannabis use was relatively benign, problems associated with use of the drug are now well recognised (Copeland and Swift, 2009; De Graaf et al., 2010; Hall and Degenhardt, 2009; Hall and Pacula, 2003).”
Proudfoot, H., & Teesson, M. (2002) · Social Psychiatry and Psychiatric Epidemiology · doi:10.1007/s00127-002-0576-1 · Cited by 71
Self-citationSubstance Use and Mental Health in Longitudinal Perspective
Teesson, M., Degenhardt, L. J., Hall, W., Lynskey, M. T., Toumbourou, J. W., & Patton, G. C. (2005) · Wiley eBooks · doi:10.1002/9780470713624.ch4 · Cited by 44 · cited 1×
“The current findings highlight clearly the need for effective prevention and early detection of cannabis use disorders, given the significant detrimental psychosocial outcomes associated with cannabis use (Teesson et al., 2005).”
BackgroundSelf-citationDegenhardt, L. J., Bohnert, K. M., & Anthony, J. C. (2007) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2007.09.024 · Cited by 42 · cited 3×
“The rates of use reported herein are similar to those reported in European countries, particularly France (19.0), Germany (17.5) and the Netherlands (19.8) (Degenhardt et al., 2008, Kessler and Ustun, 2004, Kessler et al., 2005, Wells et al., 2006).”
InfluentialDegenhardt, L., Bohnert, K. M., & Anthony, J. C. (2007) · International Journal of Methods in Psychiatric Research · doi:10.1002/mpr.220 · Cited by 40 · cited 1×
“Sequencing problems in earlier versions of the WMH-CIDI substance use section were also resolved (Degenhardt et al., 2007a, 2007b; Grant et al. 2007)to enable the diagnosis of cannabis dependence to be made in the absence of cannabis abuse.”
Assessing cannabis dependence in community surveys: methodological issues
Degenhardt, L., Cheng, H., & Anthony, J. C. (2007) · International Journal of Methods in Psychiatric Research · doi:10.1002/mpr.206 · Cited by 32 · cited 1×
“Sequencing problems in earlier versions of the WMH-CIDI substance use section were also resolved (Degenhardt et al., 2007a, 2007b; Grant et al. 2007)to enable the diagnosis of cannabis dependence to be made in the absence of cannabis abuse.”
McBride, O., Teesson, M., Slade, T. N., Hasin, D. S., Degenhardt, L. J., & Baillie, A. (2008) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2008.10.011 · Cited by 27 · cited 4×
“A cross-national comparison with the US National Comorbidity Survey found that although rates of use of cannabis were similar in the two countries, rates of cannabis dependence and the probability of dependence among users were higher in Australia than in the USA (McBride et al., 2009; Teesson et al., 2006).”
InfluentialSelf-citation
Research works printed but not linked: 1
- United Nations Office on Drugs and Crime, 2009, World Drug Report
Cited by
Hasin, D. S., Kerridge, B. T., Saha, T. D., Huang, B., Pickering, R., Smith, S. M., Jung, J., Zhang, H., & Grant, B. F. (2016) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2015.15070907 · Cited by 579
“The prevalence and odds of 12-month and lifetime cannabis use disorders were greater among men than women, consistent with earlier surveys (17, 50, 51).”
ResultCannabis use and cannabis use disorder
Connor, J. P., Stjepanović, D., Le Foll, B., Hoch, E., Budney, A. J., & Hall, W. D. (2021) · Nature Reviews Disease Primers · doi:10.1038/s41572-021-00247-4 · Cited by 552
Self-citationHunt, G. E., Malhi, G. S., Lai, H. M. X., & Cleary, M. (2020) · Journal of Affective Disorders · doi:10.1016/j.jad.2020.01.141 · Cited by 289
Psychosocial interventions for cannabis use disorder
Gates, P. J., Sabioni, P., Copeland, J., Le Foll, B., & Gowing, L. (2016) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd005336.pub4 · Cited by 282
Analysis of Cannabis Seizures in NSW, Australia: Cannabis Potency and Cannabinoid Profile
Swift, W., Wong, A., Li, K. M., Arnold, J. C., & McGregor, I. S. (2013) · PLoS ONE · doi:10.1371/journal.pone.0070052 · Cited by 182
“Globally, Australia has one of the highest rates of cannabis use [26,27], while the occurrence of population indicators of cannabisrelated harm, including hospital separations for cannabis-induced psychosis and cannabis-related problems such as dependence, increased over the 2000s [28].”
BackgroundSelf-citation
Metadata
- Authors
- Teesson, M., Slade, T., Swift, W., Mills, K., Memedovic, S., Mewton, L., Grove, R., Newton, N., & Hall, W.
- Affiliations
- UNSW Sydney (AU)
- The University of Queensland (AU)
- ORCID
- Venue
- Australian & New Zealand Journal of Psychiatry
- Publisher
- SAGE Publications
- Published
- 2012-09-14
- Volume
- 46
- Issue
- 12
- Pages
- 1182-1192
- ISSN
- 0004-8674 (ISSN-L)
- 1440-1614
- OpenAlex
- W1989744420
- Cited by
- 72
- References
- 35
- Citations by year
- 2026: 3 · 2025: 3 · 2024: 5 · 2023: 4 · 2022: 1 · 2021: 11 · 2020: 3 · 2019: 7 · 2018: 7 · 2017: 7 · 2016: 9 · 2015: 2 · 2014: 2 · 2013: 6 · 2012: 1
- FWCI
- 2.58
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- journals.sagepub.com/page/policies/text-and-data-mining-license (tdm)
- Locations
- Australian & New Zealand Journal of Psychiatry (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Cannabis and Cannabinoid Research
- Health Sciences › Medicine › Epidemiology › Substance Abuse Treatment and Outcomes
- Health Sciences › Medicine › Psychiatry and Mental health › Mental Health Treatment and Access
- Keywords
- cannabis use disorder, cannabis use prevalence, psychiatric comorbidity, alcoholism, mood disorders, treatment seeking, DSM-IV, Australia
- MeSH terms
- Adolescent, Adult, Age Factors, Aged, 80 and over, Alcohol Drinking, Australia, Cannabis, Marijuana Abuse, Demography, Female, Health Surveys, Humans, Male, Patient Acceptance of Health Care, Psychiatric Status Rating Scales, Risk Factors, Sex Factors, Socioeconomic Factors, Comorbidity, Prevalence, Diagnosis, Dual (Psychiatry), Mood Disorders, Diagnostic and Statistical Manual of Mental Disorders
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.